About the Journal

Aims & Scope

The Journal of Endocrine Breast and Metabolic Research (JEBMR) is an international peer-reviewed academic journal dedicated to advancing knowledge and innovation in the interdisciplinary fields of endocrine sciences, breast diseases, and metabolic disorders. Endocrinology and metabolism are fundamental to human physiology, regulating growth, reproduction, energy balance, and homeostasis; disruptions in hormonal systems lead to numerous clinical conditions such as thyroid disorders, diabetes, obesity, infertility, and reproductive endocrine diseases.

JEBMR aims to provide a high-quality platform for clinicians, surgeons, researchers, academicians, and healthcare professionals to publish cutting-edge research that enhances the understanding, diagnosis, and treatment of endocrine, breast, and metabolic diseases. The journal encourages scientific dialogue and dissemination of knowledge through original research articles, reviews, clinical studies, translational research, case reports, systematic reviews, meta-analyses, and innovative technological approaches including artificial intelligence.

Scope of the Journal

JEBMR covers a wide spectrum of basic, translational, clinical, and surgical research related to endocrine glands, breast diseases, and metabolic disorders. The journal welcomes interdisciplinary research integrating molecular biology, genetics, imaging, bioinformatics, surgical innovations, and digital health technologies. Modern endocrine research often spans from molecular mechanisms and hormonal signaling to clinical treatment strategies and public health implications.

The journal accepts manuscripts addressing the following areas, though not limited to:
1. Endocrine Gland Disorders
Research focusing on the physiology, pathology, diagnosis, and management of disorders involving endocrine glands such as:

• Thyroid diseases including goiter, thyroiditis, nodules, and thyroid cancer.
• Parathyroid disorders including hyperparathyroidism and calcium metabolism.
• Adrenal gland diseases such as adrenal tumors, Cushing’s syndrome, and adrenal insufficiency.
• Pituitary gland disorders including prolactinoma, acromegaly, and hormonal dysregulation.
• Thymus-related endocrine and immunological interactions.

2. Breast and Endocrine Oncology
The journal encourages research on the hormonal and metabolic aspects of breast diseases including:

• Benign breast disorders and breast cancer.
• Hormone receptor biology and endocrine therapy.
• Surgical management of breast diseases.
• Imaging, diagnostics, and screening innovations.
• Translational research linking hormonal signaling and breast pathology.

3. Reproductive and Gynecological Endocrinology
JEBMR welcomes studies related to reproductive hormonal disorders and women’s health including:

• Polycystic ovarian syndrome (PCOS).
• Ovarian endocrine disorders.
• Infertility and reproductive endocrinology.
• Hormonal regulation of menstrual and reproductive cycles.
• Assisted reproductive technologies and metabolic influences.

4. Metabolic Disorders and Lifestyle Diseases
Metabolic diseases constitute a major global health challenge. The journal publishes research related to:

• Diabetes mellitus and insulin resistance.
• Obesity and metabolic syndrome.
• Lipid metabolism and endocrine regulation of energy balance.
• Nutritional endocrinology and metabolic health.
• Cardiometabolic risk associated with endocrine diseases.

5. Surgical Endocrinology and Interventional Approaches
JEBMR promotes research in advanced surgical techniques and interventional management including:

• Endocrine surgery involving thyroid, parathyroid, adrenal, and breast glands.
• Minimally invasive and robotic surgical procedures.
• Surgical outcomes and innovations.
• Multidisciplinary management of endocrine tumors.

6. Basic and Translational Research
The journal also encourages fundamental scientific research aimed at understanding the molecular and cellular basis of endocrine and metabolic diseases, including:

• Hormone signaling pathways.
• Genetic and epigenetic regulation of endocrine function.
• Molecular biomarkers and precision medicine.
• Experimental models and translational discoveries bridging laboratory and clinical practice.

7. Artificial Intelligence and Emerging Technologies

JEBMR actively supports research involving artificial intelligence, machine learning, and computational modeling in endocrine and breast research. AI-driven approaches are increasingly being used for early detection, diagnostic imaging interpretation, treatment prediction, and personalized medicine strategies.

Aim of the Journal

The primary aim of JEBMR is to promote high-quality scientific research and encourage academic collaboration in endocrine, breast, and metabolic sciences. The journal seeks to bridge the gap between basic research and clinical practice by publishing innovative studies that improve patient care, surgical outcomes, and preventive strategies.

Objectives

The key objectives of JEBMR include:

• Promoting multidisciplinary research integrating endocrinology, breast science, surgery, metabolism, and reproductive medicine.
• Encouraging young researchers, academicians, and clinicians to contribute innovative scientific work and share knowledge globally.
• Providing a platform for translational research that converts laboratory discoveries into clinical applications.
• Facilitating academic exchange through high-quality peer-reviewed publications.
• Encouraging technological advancements, including artificial intelligence and digital health tools in endocrine and breast research.
• Improving clinical practice and patient outcomes through evidence-based research and scientific dissemination.

Through these objectives, the Journal of Endocrine Breast and Metabolic Research (JEBMR) aspires to become a globally recognized academic platform that supports scientific excellence, innovation, and collaborative research in endocrine, breast, and metabolic medicine.